Q. Should I be concerned about the complications of COVID-19 after one year?

Hi doctor,

I am a 34-year-old male. I got COVID-19 one year back, and I am still experiencing pain in my lungs daily (especially in the right one at the top) besides breathlessness. Today I had a CT scan, and I would like to know how it looks or if I should have a more thorough in-person evaluation.

Thanks in advance.

Hi doctor,

Thank you for your reply.

It is very relieving to know that the CT looks normal. Can this be caused by inflammation? Note that I experience this pain every day.

These are my levels, I do not have information about calcium levels, but I do have other information that may be useful (I am also attaching my blood tests to this message)

- B12 (Cobalamin): 472 μg/L

- B12 active (Holotranscobalamin): 163.1 pmol/L

- D (25-hydroxycholecalciferol): 34.2 ng/mL

- Magnesium: 1.90 mg/dL

- Ferritin: 15 ng/mL

Let me know if you need any other information.

Hi doctor,

Thanks for checking my reports.

It is greatly appreciated. I do not smoke, and I did not have any PFT done.

Luckily I can perform my daily activities without issue. However, I do notice that my lung capacity is not the same as pre-COVID. Also, exercise seems to make the pain or discomfort worse.

I have a very healthy diet, but I am slightly overweight, and I forgot to mention that I had an ultrasound of my chest a couple of days ago, and it came out clear.

Hi doctor,

Thank you for the reply.

I am not from a western country, so a prescription will not be useful for me. I will try to get a pulmonary function test.

Also, can this be related to my condition? Two months ago, I had a blood exam, and my von Willebrand factor and Factor VIII were a bit high.

And I have read the following:

"Factor VIII and VWF(Ag) were elevated in 26% and 18%, respectively, and support a hypercoagulable state in some patients with PCS." and "These findings suggest possible ongoing microvascular or endothelial dysfunction in the pathogenesis of PCS and suggest a role for antithrombotic therapy in the treatment of these patients."